vs
Side-by-side financial comparison of Veritone, Inc. (VERI) and Xilio Therapeutics, Inc. (XLO). Click either name above to swap in a different company.
Veritone, Inc. is the larger business by last-quarter revenue ($26.6M vs $13.7M, roughly 1.9× Xilio Therapeutics, Inc.). Xilio Therapeutics, Inc. runs the higher net margin — 75.7% vs -109.8%, a 185.5% gap on every dollar of revenue. Xilio Therapeutics, Inc. produced more free cash flow last quarter ($-2.1M vs $-17.1M).
Veritone, Inc. is an American artificial intelligence technology company based in Irvine, California founded in 2014. It serves a variety of industries including media, professional sports teams, federal government agencies, energy utilities, and state and local police departments.
Xilio Therapeutics is a clinical-stage biotechnology company dedicated to developing novel tumor-selective immunotherapies for cancer treatment. Its product pipeline features candidates engineered to trigger anti-tumor immune responses specifically inside tumor microenvironments, reducing systemic toxicities, and it primarily targets oncology patient populations in North America and other global markets.
VERI vs XLO — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.6M | $13.7M |
| Net Profit | $-29.2M | $10.4M |
| Gross Margin | — | — |
| Operating Margin | -68.2% | -86.5% |
| Net Margin | -109.8% | 75.7% |
| Revenue YoY | 21.1% | — |
| Net Profit YoY | -34.5% | 179.1% |
| EPS (diluted) | — | $-3.74 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $13.7M | ||
| Q3 25 | $26.6M | $19.1M | ||
| Q2 25 | $23.2M | $8.1M | ||
| Q1 25 | $22.5M | $2.9M | ||
| Q4 24 | $22.4M | — | ||
| Q3 24 | $22.0M | — | ||
| Q2 24 | $24.1M | — | ||
| Q1 24 | $24.2M | — |
| Q4 25 | — | $10.4M | ||
| Q3 25 | $-29.2M | $-16.3M | ||
| Q2 25 | $-26.5M | $-15.8M | ||
| Q1 25 | $-19.9M | $-13.3M | ||
| Q4 24 | $31.8M | — | ||
| Q3 24 | $-21.7M | — | ||
| Q2 24 | $-22.2M | — | ||
| Q1 24 | $-25.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 72.6% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 71.2% | — | ||
| Q2 24 | 72.6% | — | ||
| Q1 24 | 70.8% | — |
| Q4 25 | — | -86.5% | ||
| Q3 25 | -68.2% | -10.1% | ||
| Q2 25 | -82.0% | -177.7% | ||
| Q1 25 | -96.3% | -472.7% | ||
| Q4 24 | -93.8% | — | ||
| Q3 24 | -102.3% | — | ||
| Q2 24 | -84.4% | — | ||
| Q1 24 | -100.9% | — |
| Q4 25 | — | 75.7% | ||
| Q3 25 | -109.8% | -85.4% | ||
| Q2 25 | -114.2% | -196.0% | ||
| Q1 25 | -88.5% | -452.7% | ||
| Q4 24 | 141.7% | — | ||
| Q3 24 | -98.9% | — | ||
| Q2 24 | -92.4% | — | ||
| Q1 24 | -104.3% | — |
| Q4 25 | — | $-3.74 | ||
| Q3 25 | — | $-0.11 | ||
| Q2 25 | $-0.53 | $-0.16 | ||
| Q1 25 | $-0.41 | $-0.18 | ||
| Q4 24 | $0.85 | — | ||
| Q3 24 | $-0.57 | — | ||
| Q2 24 | $-0.59 | — | ||
| Q1 24 | $-0.67 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.2M | $137.5M |
| Total DebtLower is stronger | $35.4M | — |
| Stockholders' EquityBook value | $15.5M | $35.3M |
| Total Assets | $198.6M | $154.7M |
| Debt / EquityLower = less leverage | 2.28× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $137.5M | ||
| Q3 25 | $36.2M | $103.8M | ||
| Q2 25 | $13.6M | $121.6M | ||
| Q1 25 | $16.1M | $89.1M | ||
| Q4 24 | $16.9M | — | ||
| Q3 24 | $11.4M | — | ||
| Q2 24 | $46.0M | — | ||
| Q1 24 | $90.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | $35.4M | — | ||
| Q2 25 | $37.3M | — | ||
| Q1 25 | $39.2M | — | ||
| Q4 24 | $41.2M | — | ||
| Q3 24 | $73.6M | — | ||
| Q2 24 | $75.6M | — | ||
| Q1 24 | $77.5M | — |
| Q4 25 | — | $35.3M | ||
| Q3 25 | $15.5M | $-8.1M | ||
| Q2 25 | $3.5M | $7.1M | ||
| Q1 25 | $14.8M | $10.7M | ||
| Q4 24 | $13.5M | — | ||
| Q3 24 | $-25.2M | — | ||
| Q2 24 | $-5.7M | — | ||
| Q1 24 | $14.9M | — |
| Q4 25 | — | $154.7M | ||
| Q3 25 | $198.6M | $133.7M | ||
| Q2 25 | $188.1M | $133.8M | ||
| Q1 25 | $199.6M | $103.7M | ||
| Q4 24 | $198.1M | — | ||
| Q3 24 | $336.4M | — | ||
| Q2 24 | $321.8M | — | ||
| Q1 24 | $359.6M | — |
| Q4 25 | — | — | ||
| Q3 25 | 2.28× | — | ||
| Q2 25 | 10.71× | — | ||
| Q1 25 | 2.66× | — | ||
| Q4 24 | 3.06× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.21× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.9M | $-2.0M |
| Free Cash FlowOCF − Capex | $-17.1M | $-2.1M |
| FCF MarginFCF / Revenue | -64.2% | -15.3% |
| Capex IntensityCapex / Revenue | 4.6% | 0.7% |
| Cash ConversionOCF / Net Profit | — | -0.19× |
| TTM Free Cash FlowTrailing 4 quarters | $-46.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-2.0M | ||
| Q3 25 | $-15.9M | $-17.5M | ||
| Q2 25 | $-8.2M | $-14.5M | ||
| Q1 25 | $-17.0M | $29.0M | ||
| Q4 24 | $-500.0K | — | ||
| Q3 24 | $3.6M | — | ||
| Q2 24 | $-42.7M | — | ||
| Q1 24 | $14.9M | — |
| Q4 25 | — | $-2.1M | ||
| Q3 25 | $-17.1M | — | ||
| Q2 25 | $-9.2M | $-14.9M | ||
| Q1 25 | $-18.4M | $29.0M | ||
| Q4 24 | $-1.7M | — | ||
| Q3 24 | $1.9M | — | ||
| Q2 24 | $-44.1M | — | ||
| Q1 24 | $13.1M | — |
| Q4 25 | — | -15.3% | ||
| Q3 25 | -64.2% | — | ||
| Q2 25 | -39.6% | -184.0% | ||
| Q1 25 | -81.9% | 988.3% | ||
| Q4 24 | -7.4% | — | ||
| Q3 24 | 8.6% | — | ||
| Q2 24 | -183.4% | — | ||
| Q1 24 | 54.2% | — |
| Q4 25 | — | 0.7% | ||
| Q3 25 | 4.6% | 0.0% | ||
| Q2 25 | 4.1% | 5.0% | ||
| Q1 25 | 6.0% | 0.8% | ||
| Q4 24 | 5.2% | — | ||
| Q3 24 | 7.7% | — | ||
| Q2 24 | 5.9% | — | ||
| Q1 24 | 7.6% | — |
| Q4 25 | — | -0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.02× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
VERI
| Software Products And Services | $20.9M | 78% |
| Other | $2.3M | 9% |
| Public Sector | $2.0M | 7% |
| Representation Services | $1.5M | 6% |
XLO
Segment breakdown not available.
